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Objective: We report our preliminary experience with thulium-laser endoureterotomy for managing
ureteral strictures.
Materials and Methods: From October 2008 to September 2009, 12 patients received thulium-laser
endoureterotomy for ureteral stricture at our hospital. Clinical characteristics and operative results
were retrospectively investigated. Successful treatment was deﬁned as an adequate diameter noted by
ureterorenoscopy, being free of associated symptoms, and having no obstructive uropathy on an imaging
study at follow-up.
Results: Successful treatment was observed in nine patients (75%). The three patients (25%) without
obvious improvement received a repeat thulium-laser endoureterotomy, or a double-J stent was
reinserted.
Conclusion: Our results show that a thulium-laser endoureterotomy is a safe and effective modality for
managing ureteral strictures. It was found to have a success rate similar to that of other minimally
invasive treatment modalities.
Copyright  2011, Taiwan Urological Association. Published by Elsevier Taiwan LLC.
Open access under CC BY-NC-ND license.1. Introduction
Ureteral stricture is a complicated disease frequently encoun-
tered by urologists. It is deﬁned as a narrowing of the ureter, which
causes functional obstruction. After excluding congenital ureter-
opelvic junction strictures, the most common causes of ureteral
stricture are acquired and iatrogenic.1 Urological procedures
became amajor cause of ureteral injury after the introduction of the
rigid ureteroscope in 1980.1 Other causes include passage of urinary
calculi, radiation therapy, retroperitoneal ﬁbrosis, and congenital
abnormalities.2
Compared with traditional open surgery for ureteral stricture,
minimally invasive methods are associated with a shorter hospital
stay, lower costs of treatment, and lower morbidity.1 The ﬁrst
published minimally invasive method was balloon dilatation,
which was reported by Banner et al in 1983.3 Many minimally
invasive methods for treating ureteral stricture have since been
published, including stenting, cold/hot knife incision, electro-
cautery, and laser endoureterotomy.1
The holmium:YAG (Ho:YAG) laser, which is used in several
urological applications, such as lithotripsy, resection, ablation, andackay Memorial Hospital, 92
n.
ciation. Published by Elsevier Taiwsoft-tissue incisions, was the ﬁrst laser to be used for an endour-
eterotomy. Recently, a thulium laser was used in transurethral
surgery for incision, excision, and ablation of bladder, prostatic, and
urethral tissues. However, to our knowledge, a thulium-laser
endoureterotomy has not been reported in the medical literature.
In this study, we report our preliminary experience with
thulium-laser endoureterotomy for managing ureteral stricture.2. Materials and methods
In this series, 12 patients received a thulium-laser endoureter-
otomy for ureteral stricture at our hospital from October 2008 to
September 2009. The indications for an endoureterotomy included
the presence of clinical symptoms, hydronephrosis on renal ultra-
sonography, ureteral stricture on intravenous urography, decreased
renal function by diuretic renal functional scan, and ureteral stric-
ture during previous ureterorenoscopy. Before surgery, the perti-
nent medical history, including urolithiasis, radiation therapy, and
previous associated operations, was recorded. Renal function and
associated radiographic images, including renal ultrasonography
and intravenous urography, were examined. No patient received
a regular course of anti-inﬂammatory agents as adjuvant therapy
for ureteral stricture. A renal function scan was performed on
demand. The length of the ureteral stricture was measured by
intravenous urography or recorded during the operation. The lesionan LLC Open access under CC BY-NC-ND license..
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upper border of the sacrum, in the lower segment if it was below
the lower border of the sacrum, and in the middle if it was within
the sacrum on radiological studies.
All patients received retrograde ureterorenoscopy (6-Fr. Wolf,
Knittlingen, Germany). A guidewire (0.89 mm  150 cm, Teﬂon
coated; St. Jude Medical, Minnetonka, MN, USA) was passed
through the stricture segment under direct endoscopic vision if
possible. A thulium-laser ﬁber was used to incise the ureteral wall
on the lateral side in cases of proximal ureteral stricture to avoid the
medial great vessels, and on the medial side in cases of distal
ureteral stricture to avoid the iliac vessels. The wavelength of the
thulium laser was 2013 nm, and the power was initially set to
approximately 5 W and gradually increased to 15 W if necessary.
The incision was made until the ureteral serosal tissue became
visible. We moved the ureteroscope from the proximal point to the
distal point of the stricture to record the length of the stricture. The
adequacy of the incision was judged by the ability of the ureter-
orenoscope to pass the stricture segment. A double-J catheter (6-
Fr.  24 cm, hydrophilic coated, Cook Ireland Ltd., Limerick,
Ireland) was inserted in all cases for stenting. All patients received 1
day of intravenous antibiotics as prevention and then were
switched to oral quinolone for 1 week if no urinary tract infection
was noted.
The duration of double-J stenting was based on the surgeon’s
judgment, and all cases were reevaluated by ureterorenoscopy after
stent removal. If ureteral stricture persisted, a new double-J cath-
eter was inserted for stenting. In cases in which the stent was
removed, renal ultrasonography and intravenous urography were
performed in the ﬁrst week and month, respectively. Successful
treatment was deﬁned as an adequate diameter noted by ureter-
orenoscopic reevaluation with no resistance to the passage of the
ureteroscope, being free of associated symptoms, and having no
obstructive uropathy on imaging studies, or improvement in renal
function on a split renal function scan at 3-month follow-up.
3. Results
The cause of ureteral stricture in our series was stone impaction
in ﬁve patients, iatrogenic in three patients, trauma in one patient,
and unknown in three patients (Table 1). The length of the ureteral
stricture ranged from 0.31 cm to 2.0 cm (0.8  0.17 cm), excluding
two patients without measurements. A left-sided stricture was
observed in eight patients and a right-sided stricture in four
patients. Seven strictures occurred in the proximal ureter and ﬁve
in the distal ureter. During reevaluation, successful treatment was
observed in nine patients (75%), and double-J stents wereTable 1
Clinical characteristics and operative results
Case Sex Associated operation Possible etiology S
1 F Balloon dilatation Unknown R
2 M Nil Trauma L
3 M URSL Recurrent stone impaction R
4 F URS Unknown L
5 F URSL Recurrent stone impaction L
6 F 1. LAVH
2. Ureteroureterostomy
Iatrogenic L
7 F 1. ATH þ BSO
2. URSL
Recurrent stone formation R
8 F Nil Recurrent stone formation L
9 M URSL Recurrent stone impaction L
10 F Nil Unknown R
11 F URSL Iatrogenic L
12 F URSLs Iatrogenic L
ATH ¼ abdominal total hysterectomy; BSO ¼ bilateral salpingoopherectomy; DJ ¼ do
M ¼ male; URS ¼ ureteroscopy; URSL ¼ ureterorenoscopic lithotripsy.reinserted in the other three patients (25%). All patients with a left-
sided stricture had good results, but only one of the four patients
with a right-sided stricture showed improvement. In the other
three patients, thulium-laser endoureterotomywas repeated in one
patient and double-J catheter re-stenting was performed in all
three cases. In this series, two of three patients with a ureteral
stricture exceeding 1.0 cm needed double-J catheter insertion.
Postoperative feverwas observed in two patients (16.7%) because of
a urinary tract infection, which subsided after antibiotic treatment.
No major complication was recorded among our cases.
4. Discussion
Urological procedures have replaced gynecological and general
surgery as the major cause of ureteral stricture after the advent of
ureterorenoscopy. Urological iatrogenic factors include direct
mechanical trauma, such as perforation, relative ischemia from
large-caliber ureteral instruments, and thermal injury.4
Traditionally, open ureterotomy and ureteral reimplantation
were the most common methods for managing ureteral strictures
before the advent of minimally invasive methods. These open
surgical methods were associated with longer hospitalization,
higher morbidity, and higher costs of treatment.5 In 1983, Banner
et al3 reported the use of balloon dilatation for ureteral strictures. In
that same year, Wickham ﬁrst reported endoscopic treatment of
obstruction at the ureteropelvic junctionusing a cold-knife ure-
throtome to incise the ureteropelvic junction using a percutaneous
nephrostomy tract.6 Various endoscopic treatment modalities have
been reported to date, including stenting, cold/hot knife incision,
electrocautery, and laser endoureterotomy7; however, none of
them has become the standard procedure. Cold-knife ureterotomy
may seem attractive because of elimination of heat injury to the
surrounding tissue. However, it can only be used with a large-
caliber ureteroscope, which may be difﬁcult to pass through
a non-dilated ureter, particularly a segment with a stricture.
Therefore, use of the cold knife in a retrograde fashion is usually
limited to the distal ureter.5
The ideal energy source for an endoureterotomy should be
capable of providing a reliable full-thickness incision of a stricture
segment without causing signiﬁcant damage to surrounding
tissues. Furthermore, alternate energy sources should be compat-
ible with ﬂexible and rigid endoscopes of all sizes and provide
simultaneous hemostasis while cutting to provide a clear ﬁeld of
view during endoscopic surgery. Laser energy, which possesses
both cutting and hemostatic properties, may provide an advantage
over cold-knife ureterotomy. The Ho:YAG laser is the most popular
laser used for endoureterotomies. It is a solid-state laser withtricture site, length (cm) Duration of DJ (mo) DJ reinsertion
ight lower with poor opaciﬁcation 1 þ 3 þ
eft upper (no measurement) 3 d
ight upper, 1.5 3 þ
eft upper, 0.31 3 d
eft upper, 0.47 1 d
eft lower, 2.0 3 d
ight lower, 0.85 1 d
eft upper, 0.91 3 d
eft lower, 0.42 2 d
ight upper, 1.28 3 þ
eft upper, 0.75 3 d
eft lower, 0.66 2 d
uble-J stent; F ¼ female; LAVA ¼ laparoscopically assisted vaginal hysterectomy;
Table 2
Success rates of minimally invasive surgical modalities for urethral stricture
Reference Endoscopic method Success rate (%)
10 Balloon dilatation 48 and 82
12
13 Ho:YAG laser 68.4e90.0
14
7
15
5
2 Acucise or hot/cold knife and balloon 53e82
16
11
Our series Thulium laser 75
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a depth of less than 0.5 mmwith good hemostasis are possible. The
reusable 400-mm bare laser ﬁber can be placed through small
endoscopes and still allow for adequate irrigation. Tissue studies
have shown that the Ho:YAG laser’s peripheral zone of thermal
injury is 0.5e1 mm.8
The thulium laser belongs to a new generation of laser ﬁbers,
and it has been applied in transurethral surgery for rapid vapor-
ization and incision of the prostate. It has a tunable wavelength of
1.75e2.22 mm and operates at a wavelength of 1.94 mm, because
that is its water absorption peak in tissues. It can work in
a continuous-wave mode for maximum hemostasis and coagula-
tion, or a pulsed mode when precision cutting is required. The laser
beam diameter, which is only 18 mm, allows for better spatial beam
quality. According to the literature, the thermal-coagulation zone is
400e600 mm during incisions of bladder and ureter tissues.9 The
thulium laser has several potential advantages over the Ho:YAG
laser, including a smaller size, more efﬁcient operation, more
precise incision of tissues, and the ability to operate in either
a pulsed- or continuous-wave mode.
A review of the medical literature has shown that success rates
of different treatment methods for ureteral stricture vary from 48%
to 90% (Table 2).2,6,10e16 No singlemethod can provide an absolutely
superior success rate. In our series, the success rate of thulium-laser
endoureterotomy was 75%, which is similar to rates previously
reported for other lasers. Stricture length plays an important role in
the probability of success of the endoureterotomy. Short strictures,
particularly those that are less than 1 cm long, respond better than
longer strictures. Most investigators would probably agree that
regardless of the endoscopic technique employed, endoureter-
otomy performed on short (<1 cm) solitary strictures with a good
blood supply and involving the distal ureter have the greatest
chance of success.17 In our study, patients with a ureteral stricture
of less than 1.0 cm long had the best results with no need for
a reoperation or double-J catheter reinsertion. For endopyelotomic
incisions, the traditional cutoff for declining success is less than
2 cm. Dense, completely occluded ureteral strictures have a lower
chance of success with an endoureterotomy. Wolf et al found that
patients with poor ipsilateral renal function of less than 25% of total
renal function were unlikely to achieve stent-free patency after an
endoscopic ureteral incision.2 Ischemic benign ureteral strictures
and ureteroenteric strictures also have lower success rates
compared with non-ischemic benign ureteral strictures following
an endoureterotomy. Repeat endoureterotomies are associatedwith a poor prognosis, and repeated thermal injury may cause
more ischemic change.
There is no standard duration of stenting after an endoureter-
otomy. According to initial studies by Davis et al, the mucosa
regenerates within 1 week, and the ureteral muscle regenerates
and regains peristalsis by 6 weeks.18 In our series, the stents were
removed 1e3 months after surgery at the surgeon’s discretion, and
no difference in success rates was found. Even though there is no
standard timetable for follow-up after an endoureterotomy, Wolf
et al recommended radiographic follow-up using diuretic renog-
raphy for up to 3 years to detect late failures.2 According to a report
by Gnessin et al, most failures occur within 9 months of surgery,
which may indicate a need for closer follow-up during the ﬁrst
postoperative year.5
5. Conclusions
Our experience shows that a thulium-laser endoureterotomy is
a safe and effectivemodality for managing ureteral strictures. It was
found to have a similar success rate as other minimally invasive
treatment modalities. Stricture length plays an important role in
the prognosis. Larger studies with longer follow-up are required to
prove any superiority.
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